Viewing Study NCT05165433


Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2025-12-30 @ 5:05 PM
Study NCT ID: NCT05165433
Status: COMPLETED
Last Update Posted: 2025-12-16
First Post: 2021-12-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY)
Sponsor: Akamis Bio
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module